Cancer
Malignant Liver Neoplasm
CI-CAN-00003177Explore in graph →
Top-level907 active trials14 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003177Explore in graph →
Clinical trials
4,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (462)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00777894 | Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | completed | Phase 1 / Phase 2 | 18 | Swiss Cancer InstituteOTHER | 2 | May 15, 2019 | clinicaltrials |
| NCT01005199 | Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer | completed | Phase 2 | 106 | Swiss Cancer InstituteOTHER | 3 | May 15, 2019 | clinicaltrials |
| NCT01008917 | Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma | completed | Phase 1 | 25 | University of California, San FranciscoOTHER | 1 | May 9, 2019 | clinicaltrials |
| NCT00586235 | Registration and Fusion of Real-Time Ultrasound With CT for Lesion Localization and Characterization | completed | — | 80 | Mayo ClinicOTHER | 1 | May 6, 2019 | clinicaltrials |
| NCT02471313 | Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization | completed | Phase 2 | 3 | National Institutes of Health Clinical Center (CC)NIH | 1 | Apr 23, 2019 | clinicaltrials |
| NCT02145559 | A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | University of ChicagoOTHER | 1 | Apr 22, 2019 | clinicaltrials |
| NCT03300414 | Biologic Basis of Liver Cancer From Chronic Hepatitis B | completed | — | 2 | University of California, DavisOTHER | 1 | Apr 11, 2019 | clinicaltrials |
| NCT00397540 | The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) | completed | N/A | 145 | Seoul National University HospitalOTHER | 1 | Mar 18, 2019 | clinicaltrials |
| NCT02271646 | Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation | completed | N/A | 35 | Mahidol UniversityOTHER | 1 | Mar 12, 2019 | clinicaltrials |
| NCT01952353 | Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion | completed | Phase 4 | 330 | Sun Yat-sen UniversityOTHER | 1 | Mar 7, 2019 | clinicaltrials |
| NCT01229839 | Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC | completed | Phase 3 | 668 | Sun Yat-sen UniversityOTHER | 1 | Mar 6, 2019 | clinicaltrials |
| NCT01259414 | Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma | completed | Phase 3 | 812 | Sun Yat-sen UniversityOTHER | 1 | Mar 6, 2019 | clinicaltrials |
| NCT02981498 | Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma | completed | Phase 2 | 35 | Sun Yat-sen UniversityOTHER | 1 | Mar 6, 2019 | clinicaltrials |
| NCT02151864 | LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis | completed | Phase 1 | 9 | Jason K. Sicklick, M.D.OTHER | 1 | Mar 5, 2019 | clinicaltrials |
| NCT02587793 | Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the Patients | completed | — | 208 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT02425605 | Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma | completed | Phase 2 | 47 | Yonsei UniversityOTHER | 1 | Feb 25, 2019 | clinicaltrials |
| NCT03852238 | Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study)(NoFlic) | completed | — | 283 | University Hospital, BordeauxOTHER | 1 | Feb 25, 2019 | clinicaltrials |
| NCT01619475 | Adult-to-Adult Living Donor Transplant Cohort Study(A2ALL-2) | completed | — | 1,871 | Arbor Research Collaborative for HealthOTHER | 2 | Feb 8, 2019 | clinicaltrials |
| NCT00441376 | A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver | completed | Phase 1 | 30 | ImunonINDUSTRY | 1 | Feb 7, 2019 | clinicaltrials |
| NCT00946153 | Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 66 | Eisai Co., Ltd.INDUSTRY | 2 | Feb 1, 2019 | clinicaltrials |
| NCT01010126 | Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer | completed | Phase 2 | 252 | National Cancer Institute (NCI)NIH | 2 | Jan 25, 2019 | clinicaltrials |
| NCT01306058 | Sorafenib and TRC105 in Hepatocellular Cancer | completed | Phase 1 / Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2019 | clinicaltrials |
| NCT02191878 | Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 43 | Arbutus Biopharma CorporationINDUSTRY | 6 | Jan 16, 2019 | clinicaltrials |
| NCT01210495 | Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma | completed | Phase 2 | 224 | PfizerINDUSTRY | 13 | Jan 9, 2019 | clinicaltrials |
| NCT03176485 | Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors | completed | N/A | 45 | University of ArizonaOTHER | 1 | Jan 4, 2019 | clinicaltrials |
| NCT01258608 | Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 101 | Human Genome Sciences Inc., a GSK CompanyINDUSTRY | 7 | Dec 19, 2018 | clinicaltrials |
| NCT03775863 | AFP Model and Liver Transplantation. | completed | — | 1,200 | Austral University, ArgentinaOTHER | 2 | Dec 19, 2018 | clinicaltrials |
| NCT00243841 | Dose Escalation Study for Primary Hepatocellular Carcinoma(SBF-HCC) | completed | N/A | 77 | Indiana UniversityOTHER | 1 | Dec 13, 2018 | clinicaltrials |
| NCT02073435 | A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation | completed | — | 177 | Northwestern UniversityOTHER | 1 | Dec 5, 2018 | clinicaltrials |
| NCT02069041 | A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer | completed | Phase 1 | 8 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 21, 2018 | clinicaltrials |
| NCT02649712 | Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction | completed | N/A | 72 | Xuzhou Central HospitalOTHER | 1 | Nov 20, 2018 | clinicaltrials |
| NCT02960594 | hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse(TRT-001) | completed | Phase 1 | 93 | Inovio PharmaceuticalsINDUSTRY | 1 | Nov 19, 2018 | clinicaltrials |
| NCT00827723 | Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma | completed | — | 60 | University of Lausanne HospitalsOTHER | 1 | Nov 13, 2018 | clinicaltrials |
| NCT00004136 | Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer | completed | Phase 2 | 59 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 6, 2018 | clinicaltrials |
| NCT01933945 | Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib(OPTIMIS) | completed | — | 1,676 | BayerINDUSTRY | 31 | Nov 6, 2018 | clinicaltrials |
| NCT02269995 | Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma | completed | — | 300 | Eisai Co., Ltd.INDUSTRY | 1 | Nov 5, 2018 | clinicaltrials |
| NCT00077142 | TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) | completed | Phase 1 / Phase 2 | 37 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT02966509 | Engagement of Patients With Advanced Cancer(EPAC) | completed | N/A | 213 | Stanford UniversityOTHER | 0 | Oct 31, 2018 | clinicaltrials |
| NCT03595345 | A Worldwide Score for Hepatocellular Cancer and Liver Transplantation(TRAIN-SCORE) | completed | — | 3,100 | European Hepatocellular Cancer Liver Transplant GroupOTHER | 1 | Oct 29, 2018 | clinicaltrials |
| NCT03723304 | The Intention-to-treat Effect of Bridge Therapies in the Setting of Milan-in Patients | completed | — | 1,083 | European Hepatocellular Cancer Liver Transplant GroupOTHER | 1 | Oct 29, 2018 | clinicaltrials |
| NCT03299036 | Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy | completed | N/A | 12 | National Cheng-Kung University HospitalOTHER | 1 | Oct 22, 2018 | clinicaltrials |
| NCT02833298 | Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening | completed | N/A | 25 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 12, 2018 | clinicaltrials |
| NCT01360255 | AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE) | completed | — | 70 | University Hospital FreiburgOTHER | 1 | Oct 11, 2018 | clinicaltrials |
| NCT03698643 | Impact of New Interventional Imaging Modality Use on Patient Radiation Exposure in Transarterial Chemoembolization | completed | — | 145 | University Hospital, MontpellierOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT01395030 | PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection | completed | Phase 2 | 64 | Queen's Medical CenterOTHER | 1 | Sep 26, 2018 | clinicaltrials |
| NCT01590732 | Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma | completed | Phase 1 | 22 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 19, 2018 | clinicaltrials |
| NCT00019474 | Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer | completed | Phase 2 | 60 | Montefiore Medical CenterOTHER | 1 | Sep 14, 2018 | clinicaltrials |
| NCT01409499 | Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC)(2011PTAHCC) | completed | Phase 4 | 180 | Sun Yat-sen UniversityOTHER | 1 | Sep 11, 2018 | clinicaltrials |
| NCT00357422 | Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC) | completed | N/A | 36 | Seoul National University HospitalOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT01273766 | Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies | completed | Phase 2 | 16 | Wake Forest University Health SciencesOTHER | 1 | Sep 7, 2018 | clinicaltrials |
Data updated 24 days agoSource updated May 15, 2019source: clinicaltrials